Skip to content
Screener

Maravai LifeSciences Holdings, Inc. MRVI Q1 2025 earnings

Reported May 12, 2025 · After market close

Revenue$46.9MBeat by $2.8M
EPS-$0.08Miss by $0.01
Revenue estimate$44.0M
EPS estimate-$0.07

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$43.7M
EPS estimate-$0.06

Financials

Q1 2025

Income statement

See full
Revenue$46.9M-27.0%
Gross profit$7.7M-70.1%
Operating income-$49.2M-161%
Net income-$29.9M-148%
EPS (diluted)-$0.21-133%

Balance sheet

See full
Cash & equivalents$285.1M-49.3%
Total debt$326.7M-41.9%
Total equity$300.6M-26.8%
Total assets$959.8M-33.6%

Cash flow

See full
Operating cash flow-$9.4M-10.9%
CapEx$4.5M-20.5%
Free cash flow-$13.9M+1.7%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$317.47M-85.5%
Enterprise value$359.07M-83.6%
P/S1.3×-6.7×

Profitability

See full
Gross margin37.3%-6.7pp
Operating margin-109.9%-140pp
Net margin-67.3%+46.2pp

Returns & leverage

See full
Return on equity-45.8%+77.0pp
Debt / equity1.1×-0.3×
Current ratio6×-5.4×

Segments

By geography

See full
Asia Pacific$10.6M-50.1%
Europe, the Middle East and Africa$6.9M-26.6%
Latin and Central America$146.0K-52.4%

FAQ

When did Maravai LifeSciences Holdings, Inc. report Q1 2025 earnings?
Maravai LifeSciences Holdings, Inc. (MRVI) reported Q1 2025 earnings on May 12, 2025 after market close.
What were Maravai LifeSciences Holdings, Inc.'s Q1 2025 revenue and EPS?
Maravai LifeSciences Holdings, Inc. reported revenue of $46.9M and eps of $-0.08 for Q1 2025.
Did Maravai LifeSciences Holdings, Inc. beat estimates in Q1 2025?
Revenue beat the consensus estimate of $44.0M by $2.8M. EPS missed the consensus estimate of $-0.07 by $0.01.
How did Maravai LifeSciences Holdings, Inc.'s Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 27.0% from $64.2M a year earlier and eps declined 300.0% from $-0.02.
Where can I find Maravai LifeSciences Holdings, Inc.'s Q1 2025 SEC filings?
You can read the 8-K earnings release (0001823239-25-000062) and the 10-Q periodic report (0001823239-25-000063) directly on SEC EDGAR. The filing index links above go to sec.gov.